- Retraction Note
- Open Access
Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway
Cancer Cell International volume 19, Article number: 359 (2019)
Retraction to: Cancer Cell Int (2019) 19:60 https://doi.org/10.1186/s12935-019-0778-1
The editor has retracted this article  because Fig. 2f has been duplicated from Fig. 6j in a previously published article . In addition, the article contains sections that substantially overlap with a previously published article . The data reported in this article are therefore unreliable.
Xue Shao agrees to this retraction. Jie Song, Wei Zhao, and Chang Lu have not responded to any correspondence from the editor/publisher about this retraction.
Song J, Zhao W, Lu C, Shao X. LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK–Mfn2 signaling pathway. Cancer Cell Int. 2019;19:60. https://doi.org/10.1186/s12935-019-0778-1.
Jieensinue S, Zhu H, Li G, Dong K, Liang M, Li Y. Tanshinone IIA reduces SW837 colorectal cancer cell viability via the promotion of mitochondrial fission by activating JNK-Mff signaling pathways. BMC Cell Biol. 2018;19:21. https://doi.org/10.1186/s12860-018-0174-z.
Hou Y, Lan C, Kong Y, Zhu C, Peng W, Huang Z, Zhang C. Genetic ablation of TAZ induces HepG2 liver cancer cell apoptosis through activating the CaMKII/MIEF1 signaling pathway. OncoTargets Ther. 2019;12:1765–79. https://doi.org/10.2147/OTT.S196142.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Song, J., Zhao, W., Lu, C. et al. Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway. Cancer Cell Int 19, 359 (2019). https://doi.org/10.1186/s12935-019-1084-7